New analyses in ALS planned to aid CNM-Au8’s accelerated approval
Clene is collaborating with APST Research to further explore how CNM-Au8 affects levels of neurofilament light chain (NfL) among…
Articles by Lindsey Shapiro, PhD
ALS Association issues statement opposing planned NIH funding cuts
The ALS Association, a U.S.-based nonprofit whose mission is to help find a cure for amyotrophic lateral sclerosis…
ALS patients offer perspectives on having access to prognostic test data
Having access to results from prognostic tests — including neurofilament light chain (NfL) and the ALS Functional Rating Scale-Revised (ALSFRS-R)…
AB Science to launch new Phase 3 trial of masitinib for ALS
AB Science will launch a new Phase 3 clinical trial to test its investigational oral therapy masitinib in people…
New ALS trial data show nearly 2-year survival benefit with NP001
NP001 (sodium chlorite) was associated with a significant survival benefit among a subset of amyotrophic lateral sclerosis (ALS) patients…
Riluzole and blood sugar-boosting diet interact to slow ALS: Study
A diet containing foods that quickly raise blood sugar is associated with slower amyotrophic lateral sclerosis (ALS) progression in…
DNL343, fosigotifator fail HEALEY platform trial’s main goal in ALS
The investigational oral therapies DNL343 and fosigotifator didn’t significantly slow disease progression in people with amyotrophic lateral sclerosis (ALS)…
Top 10 ALS news stories of 2024
Throughout 2024, ALS News Today brought our readers daily coverage of the latest in scientific breakthroughs, treatment advances, and…
Widetrial to manage physician network for ibudilast EAP
Widetrial, an integrated service and technology platform, is coming on board to support an expanded access program (EAP) that will…
Largest ALS patient-based stem cell, biodata resource opens for research
Answer ALS and Cedars-Sinai have made openly available their amyotrophic lateral sclerosis (ALS) patient-based stem cell and biodata…